ADaPT

Research excellence recognised at Vice Chancellor’s Awards

Griffith University’s leading researchers have been recognised at the 2020 Vice Chancellor’s Research Excellence Awards.
Published
home

Community partnership to support breast cancer research

Griffith University’s Institute for Glycomics is joining forces with the Sanctuary Cove precinct this October in a community partnership to raise funds to support vital breast cancer research. The Institute for Glycomics is home to the Australian Centre for Cancer Glycomics (A2CG), a unique national resource dedicated to cancer glycomics research. “Our unique research approach […]
Published
Arts Education Law

Vice Chancellor’s Research Excellence Awards nominees announced

Due to the impact of COVID-19, the Vice Chancellor’s Research Excellence Awards will be held virtually this year on September 15.
Published
Arts Education Law

Advance Queensland Fellowships to progress COVID-19 research

Five Griffith University researchers have been awarded Advance Queensland COVID-19 Industry Research Fellowships.
Published
home

Understanding enzymes linked to neurodegeneration and antiviral defence focus of Future Fellowship

Structural biologist Dr Thomas Ve from the Institute for Glycomics has been awarded an Australian Research Council Future Fellowship.
Published
Arts Education Law

ARC awards four Future Fellowships at Griffith

Four Griffith University researchers have been awarded Australian Research Council (ARC) Future Fellowships worth more than $3.8 million.
Published
Institute for Glycomics

Researchers from Institute for Glycomics fight antibiotic-resistant gonorrhoea

A research project by Griffith University’s Institute for Glycomics seeks to identify and develop new drugs and a vaccine to protect against antibiotic-resistant gonorrhoea. The bacteria Neisseria gonorrhoeae (Ng) causes the sexually transmitted infection gonorrhoea, which has significant impact on global health, infecting more than 100 million people each year. “In 2018, ‘super gonorrhoea’, resistant […]
Published
Institute for Glycomics

Bendigo Bank Paradise Point joins the fight against COVID-19 by supporting vital Institute research

Bendigo Bank Paradise Point Community Bank Branch, long-standing supporters of Griffith University’s Institute for Glycomics, have donated $10,000 in funding towards the Institute’s vital COVID-19 research, aiding their fight against the global pandemic. Four teams of expert scientists from the Institute for Glycomics are targeting SARS-CoV-2, the virus that causes COVID-19, to discover new vaccines […]
Published
COVID-19

New approaches to a COVID-19 treatment

Australian research into the use of convalescent plasma in clinical trials for the prevention and treatment of COVID-19 should be supported according to a leading immunologist.
Published
home

$200,000 funding boost strengthens the Australian–German alliance iCAIR® fight against COVID-19

Australian and German researchers from the international consortium iCAIR® (Fraunhofer International Consortium for Anti-Infective Research), comprising of Griffith University’s Institute for Glycomics and German partners Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), the Hannover Medical School (MHH), and newly-appointed partner the Helmholtz Centre for Infection Research (HZI), has commenced a joint project to develop […]
Published
Institute for Glycomics

Institute for Glycomics receives $100,000 grant from The Ian Potter Foundation

Griffith University’s Institute for Glycomics has been awarded a Medical Research grant of $100,000 from The Ian Potter Foundation to support their project ‘Pioneering Tissue Microdissection Glycomics for Better Patient Outcomes’. This grant will enable the acquisition of a Laser Capture Microdissection system (LCM). This new piece of equipment will be integrated into the Institute’s […]
Published
home

Early detection test for ovarian cancer closer with funding boost

Research into the development of an early detection test for ovarian cancer at Griffith University’s Institute for Glycomics has been given a $300,000 funding boost from The Bourne Foundation and a further significant funding pledge from Tour de Cure. “Despite decades of research, there is currently no easily accessible, non-invasive and reliable early detection test […]
Published
home

Study shows toxin family binds to sugar receptors on human cells to cause damage

Griffith University research has found that sugars decorating human cells allow toxins, produced by disease-causing bacteria, to bind to human cells and cause damage or death.
Published
home

The importance of listing Strep A as a Neglected Tropical Disease

Strep A, which can lead to serious illness and death if untreated, should be recognised as a Neglected Tropical Disease according to a leading infectious disease expert. Professor Michael Good AO, Principal Research Leader at Griffith University’s Institute for Glycomics, authored a paper published this week in PLOS Neglected Tropical Diseases. Neglected tropical diseases (NTDs) […]
Published
home

Institute for Glycomics wins NHMRC Investigator Grants

The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
Published
COVID-19

Impacts of research shut-down to be felt long after pandemic ends scientists warn

Lives are at risk due to ceasing research on diseases that in addition to COVID-19 have a major impact on public health warn scientists.
Published
Institute for Glycomics

Institute for Glycomics and Sienna Diagnostics to develop novel cancer diagnostic

Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal with Sienna Cancer Diagnostics Ltd to commercialise a novel cancer diagnostic tool. Together, the teams of researchers have engineered a unique protein, called SubB2M, that binds specifically to a sugar molecule only present in cancer cells – a potential […]
Published
COVID-19

Institute for Glycomics researchers tackle COVID-19

Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines and drugs to prevent or cure COVID-19. The teams are led by the Institute’s group leaders Professor Mark von Itzstein AO, Professor Michael Good AO, Professor Michael Jennings, and Professor Johnson Mak, all world-renowned research […]
Published